Filter
1556
Text search:
drug
financing
Featured
110
532
Language
Document type
958
269
108
105
52
35
16
7
2
1
1
Countries / Regions
83
71
54
48
47
44
43
43
39
38
37
36
36
30
29
27
27
25
22
21
18
16
16
15
14
14
14
13
13
11
11
10
9
7
7
7
7
6
6
6
6
6
6
5
5
5
5
5
4
4
4
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
758
94
63
42
42
11
9
Toolboxes
204
132
83
66
48
45
42
34
30
30
27
26
20
18
12
11
10
10
8
4
4
2
2
1
Bangladesh Health Systems in Transition
Celebrating ten years of success 2004-2014
“towards quality health and social welfare services”
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
Document No. : FDA/SMC/CTD/GL-CCT/2013/01
Joint actions by the Global Fund and UNAIDS are guided by a strong alignment of strategies, goals and targets. UNAIDS has worked with all stakeholders to set a common agenda and targets within the Global AIDS Strategy 2021–2026, and the United Nations General Assembly confirmed this strategy and i
...
Overview.
The COVID-19 pandemic is the latest crisis facing the world, but unless humans release their grip on nature, it won’t be the last, according to a new report by the United Nations Development Programme (UNDP), which includes a new experimental index on human progress that takes into acco
...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Union Framework for Antimicrobial Resistance Control 2
...
